North America Site Management Associate
CurrentPhase II, III, IV interventional studies and observational studies.Collaboration with Europe and Americas clinical teams.Therapeutic areas: Oncology (Lung and prostate cancer) / Medical Devices (DNA test, screening purposes), Ophthalmology (Dry eye disease and Clareon Toric IOLs), Virus Specific T-cell therapy (Adenovirus), Infectious disease (HIV), Hepatology (Tuberous Sclerosis Complex (TSC)-related Epilepsy and ALGS) and Neurology (Stroke).Achievements: 2023 & 2024 Productivity Award, Successful Sponsor Audit (March 2024 and October 2024), Conducted a successful interim analysis across 28 sites in North America. Identified and initiated sites for a challenging rare disease study. Successfully closed out a 28-site study for a key sponsor. Provided diligent onsite monitoring for sites in Western Canada and Managed French-speaking sites in Québec with expertise.